جستجوی استاد راهنمای دانشگاهی

• Cardiology
• Heart Failure
• Cardiac Surgery
• +۳ مورد دیگر

Stavros Drakos is a Professor of Internal Medicine at the University of Utah, with adjunct roles in Nutrition & Integrative Physiology and Biomedical Engineering. His academic appointments began in 2019. He holds certifications in medical licensure across the European Union and Utah. Drakos specializes in advanced heart failure, cardiogenic shock, and mechanical circulatory support. His research focuses on myocardial recovery, biomarkers, and LVAD therapies, with a strong emphasis on translational and clinical studies. Drakos' teaching activities include supervising thesis research (PhD) and courses on cardiology and shock-related topics. His work integrates clinical and molecular approaches to predict outcomes in heart failure, leveraging large registries like VAD Wean and SCAI classifications. His articles highlight advancements in LVAD weaning success, cardiogenic shock pathophysiology, and the role of biomarkers in guiding therapy. He has contributed to international guidelines on cardiogenic shock management and myocardial recovery criteria. Drakos collaborates across disciplines, including engineering and immunology, to address complex cardiovascular challenges.

• Musculoskeletal Radiology
• Magnetic Resonance Imaging
• Orthopedic Imaging
• +۵ مورد دیگر

Dr. Thomas R McCauley serves as an Associate Clinical Professor in the Department of Radiology & Biomedical Imaging at Yale School of Medicine. As a diagnostic radiologist, he specializes in musculoskeletal and body magnetic resonance imaging, with particular expertise in knee, shoulder, and spinal disorders. He emphasizes clear communication with patients, translating complex imaging results into understandable terms and integrating them into comprehensive care plans. Dr. McCauley's educational background includes: MD from University of Rochester School of Medicine & Dentistry (1984) BS from Trinity College (CT) (1980) His research focuses on advancing magnetic resonance imaging techniques for diagnosing musculoskeletal conditions. He has been instrumental in developing MRI applications during a period of significant technological advancement in radiology. Dr. McCauley has made substantial contributions to understanding meniscal tears, anterior cruciate ligament reconstructions, spinal disorders, and chondral injuries through his imaging expertise. Analysis of his publication record from 2002-2004 reveals a strong focus on diagnostic applications of MRI in orthopedic conditions, particularly knee injuries and spinal disorders. His work bridges clinical practice with imaging technology development, establishing protocols that enhance diagnostic accuracy for conditions ranging from meniscal tears to sacroiliitis in ankylosing spondylitis. Dr. McCauley maintains board certification in Diagnostic Radiology from the American Board of Radiology, originally certified in 1989. As an associate clinical professor, Dr. McCauley actively contributes to medical education at Yale School of Medicine, sharing his extensive experience in radiology with future physicians. His clinical practice focuses on applying cutting-edge imaging technology to directly improve patient diagnosis and treatment planning across various musculoskeletal conditions.

Francesco Di Virgilioمشاهده پروفایل

استاد بالینی

• Inflammation
• Neuroinflammation
• Cytokines
• +۵ مورد دیگر

Francesco Di Virgilio is a Clinical Professor at the University of Ferrara , affiliated with the Medical School and Department of Morphology, Surgery and Experimental Medicine. He has held leadership roles including Deputy Rector for Research, Dean for Education, and Departmental Chairman. Medical Doctor (MD) from University of Padova (1979) His research spans Inflammation , Neuroinflammation , Purinergic receptors , and Cancer immunology , focusing on P2X7 receptor mechanisms, cell death pathways , and immunometabolism . He has contributed to understanding apoptosis and necrosis in disease and ATP signaling . Notable awards include membership in the European Academy of Tumor Immunology (2016) and Faculty of 1000 (2012). He serves on editorial boards for journals like Inflammation , Purinergic Signalling , and American Journal of Physiology-Cell Physiology . Scientific Awards : Member of the European Academy of Tumor Immunology (2016), Member of Faculty of 1000 (2012) His 239 PubMed-indexed articles and 4 international patents highlight his work on innate immunity , metabolic disorders , and cancer .

Colleen Deaneمشاهده پروفایل

مدرس

• Muscle Biology
• Exercise Physiology
• Aging and Musculoskeletal Health
• +۴ مورد دیگر

Colleen Deane is a Lecturer in Muscle Cell Biology at the University of Southampton, focusing on mechanisms linking exercise, nutrition, aging, and spaceflight to skeletal muscle health. She holds a PhD and has conducted postdoctoral research on muscle regeneration in aging populations, NAD+ supplementation in older adults, and spaceflight-induced muscle decline. Her work includes the UK-led Molecular Muscle Experiment (MME) on the ISS. She was awarded an MRC fellowship to develop bioinformatics skills for studying muscle atrophy/hypertrophy transcriptional pathways. Research Interests: Her research spans muscle biology, space physiology, mitochondrial health, and translational nutrition. Key areas include countermeasures for muscle loss in space and aging, bioinformatics analysis of muscle transcriptional data, and nutritional interventions for metabolic dysfunction. Current projects include metabolomics-based studies on age-related musculoskeletal decline and UK-Japan collaborations in medical research. Awards: 3-year MRC Fellowship Butterfield Awards for UK-Japan Collaboration RANK Travel Grant Advising & Grants: Supervises PhD students in infection immunity and clinical neurosciences. Leads projects funded by Wessex Medical Research and The Rank Prize Funds. Collaborates on ISS experiments (MME/MME2) and clinical studies on post-acute COVID syndrome. Labs/Teams: Member of the Institute for Life Sciences and Interdisciplinary Musculoskeletal Health group.

Jaswinder Sethiمشاهده پروفایل

استاد

• Immunometabolism
• Obesity
• Metabolic diseases
• +۵ مورد دیگر

Jaswinder K. Sethi (also known as Jazz Sethi) is a Professor of Immunometabolism at the University of Southampton, Faculty of Medicine. She is also an Honorary NHS Foundation Trust Research Fellow and a member of the Institute for Life Sciences. Her research focuses on the intersection of immunology and metabolism, particularly examining how immune processes influence metabolic functions in obesity and related diseases. As Programme Co-Lead for the Integrated PhD in Biomedical Science, she plays a significant role in shaping graduate education at the university. Professor Sethi received her primary and secondary education in London and graduated with First-Class Honours in Biological Sciences from Birkbeck College, University of London in 1993. Her academic journey continued with: DPhil in physiological sciences from Oxford University (1997), supervised by Antony Galione Postdoctoral training at Harvard University with Gokhan Hotamisligil Establishment of a research group at Cambridge University (2000) Relocation of her laboratory to University of Southampton (2017) Professor Sethi's research interests center on immunometabolism, obesity, and metabolic diseases, with a particular focus on tissue remodelling and disease mechanisms. Her work investigates how adipose tissue biology contributes to systemic metabolic dysfunction, especially in non-alcoholic fatty liver disease (NAFLD). She examines the role of various fatty acids in immune cell function and how these processes contribute to the development of metabolic complications. Her research bridges basic science with clinical applications, seeking to identify novel therapeutic targets for metabolic disorders. Analysis of Professor Sethi's recent publications reveals a strong focus on adipose tissue biology and its relationship with liver disease, particularly NAFLD. Her work frequently examines how adipose tissue fibrogenesis markers correlate with liver fibrosis, and she has conducted clinical trials investigating synbiotic treatments for NAFLD. A recurring theme is the role of growth differentiation factor-15 (GDF-15) in connecting type 2 diabetes with liver fibrosis. Her research increasingly incorporates multi-omics approaches to understand the complex interplay between adipose tissue, gut microbiome, and liver function in metabolic disease. Professor Sethi has received numerous prestigious awards and fellowships throughout her career: Fellow of the Royal Society of Biology (FRSB) Wellcome Trust Career Re-entry Fellow (2017) Honorary NHS Research Fellow (2017) BBSRC David Phillips Research Fellowship (2001) Diabetes UK RD Lawrence Research Fellowship (2001) Wellcome Trust International Prize Travelling Postdoctoral Fellowship (1997) British Fulbright Senior Scholarship (1997) As an active supervisor, Professor Sethi currently mentors seven PhD students across various biomedical programs at the University of Southampton. She serves as Programme Co-Lead for the Integrated PhD in Biomedical Science and is deeply involved in teaching across undergraduate and postgraduate programs. Her research group is part of multiple collaborative networks including the Centre for Human Development, Stem Cells and Regeneration, and the NIHR Southampton Biomedical Research Centre, securing funding from major research councils including BBSRC and MRC. Professor Sethi leads a research group investigating Immunometabolic Signalling in Tissue Remodelling and Metabolic Disease. Her laboratory is part of the Institute for Life Sciences and collaborates closely with the Nutrition, Endocrinology and Metabolism research group. The team employs a multidisciplinary approach combining molecular biology, cell culture techniques including patient-derived organoids, and clinical studies to unravel the complex mechanisms linking immune function with metabolic processes in obesity-related diseases.

• Microbiology
• Genomics
• Antimicrobial Resistance
• +۳ مورد دیگر

Affiliations and Roles Liam Elbourne is a Research Fellow at the School of Natural Sciences, Macquarie University. He is actively involved in research projects such as 'Circuit Breaker: Investigating the regulatory circuits controlling expression of drug efflux pumps in Acinetobacter baumannii' and 'Characterisation of the Proteobacterial Antimicrobial Compound Efflux (PACE) family of multidrug resistance proteins'. His work is supported by initiatives under the Biomolecular Discovery and Design Research Centre. Research Interests Elbourne's research focuses on bacterial genomics, antimicrobial resistance mechanisms, microbial community dynamics in unique environments, and the development of computational tools for genomic analysis. His work bridges fundamental science and applied biotechnology, particularly in understanding pathogen evolution and environmental microbiology. Grants and Collaborations Project: Circuit Breaker (2017–Present) Project: PACE Family Research (2015–2016) He collaborates with researchers such as Paulsen, Hassan, and Tetu on topics ranging from efflux pump dynamics to synthetic biology applications.

Sallie Chisholmمشاهده پروفایل

استاد

• Marine Microbiology
• Environmental Science
• Biogeochemistry
• +۳ مورد دیگر

Sallie Chisholm is an MIT Institute Professor renowned for her pioneering research on marine microbes, particularly Prochlorococcus, the most abundant photosynthetic organism in the ocean. Her work bridges microbiology, ecology, and environmental science, focusing on microbial interactions, nutrient cycling, and climate impacts. Her research emphasizes Prochlorococcus's role in global biogeochemical cycles, including nitrogen and carbon dynamics. She explores how these microbes adapt to environmental stressors like light deprivation and nutrient scarcity, and their symbiotic relationships with heterotrophic bacteria. Notable contributions include the discovery of Prochlorococcus's metabolic cross-feeding networks and the development of genetic tools for studying these organisms. Her work has implications for understanding ocean productivity and climate change mitigation strategies. Key Projects: EDGE-FGT initiative for Prochlorococcus genetic systems, metabolic diversity studies, and extracellular vesicle research. Honors: MIT Institute Professor (2015), a rare distinction recognizing exceptional scholarly contributions. Current research explores Prochlorococcus's evolutionary adaptations, chitin utilization pathways, and the environmental drivers of microbial vesicle production.

• Oncology
• Immunology
• Genomics
• +۵ مورد دیگر

Jiawei Dai is a Research Fellow in the Department of Medical Oncology and Hematology at the Yale School of Medicine, Yale University. Their research focuses on cancer biology, immunotherapy, and genomic analysis, with a particular emphasis on lung cancer and breast cancer subtypes. Dr. Dai's work integrates computational approaches and artificial intelligence to predict therapeutic outcomes and driver genes in preclinical models. Key research interests include understanding immune-related adverse events in clinical trials, genomic alterations in precancerous tissues, and drug resistance mechanisms in tumor microenvironments. Their studies have explored synergistic effects of therapies targeting lipid metabolism in cancer, molecular profiling of breast cancer subtypes, and machine learning applications in oncology. Publications highlight contributions to lung cancer mutational profiling, DNA damage response pathways, and the prognostic value of gene expression patterns. Collaborative work bridges basic science and clinical translation, aiming to improve patient outcomes through personalized medicine strategies.

• Cardiovascular Disease
• Metabolic Disorders
• Sympathetic Nervous System
• +۴ مورد دیگر

Elisabeth Lambert is a Senior Research Fellow at Swinburne University of Technology, affiliated with the School of Health Science and the Iverson Health Innovation Research Institute. She previously worked at the Baker Heart and Diabetes Institute for 18 years. Her research focuses on cardiovascular and metabolic diseases, particularly the role of the sympathetic nervous system in conditions like hypertension, obesity, type-2 diabetes, and intellectual disability-related cardiometabolic risks. She has published over 220 papers and secured 12 NHMRC grants. Recent achievements include refining techniques for identifying brain areas linked to muscle sympathetic nerve activity and demonstrating links between sympathetic activity and vascular aging in anorexia nervosa patients. Education: PhD from the University of Paris, France. Research Interests: Mechanisms of cardiovascular and metabolic disorders, sympathetic nervous system regulation, clinical applications of neuroimaging (MEG, MRI), and translational research in hypertension and obesity. Key areas include stress-induced cardiovascular responses, renal denervation efficacy, and the impact of loneliness on vascular health. Publications: Recent work highlights brain-sympathetic interactions in stress, long-term outcomes of renal denervation, and the role of microRNAs in metabolic diseases. Articles span neurophysiology, cardiovascular risk factors, and translational clinical studies. Advising & Grants: Supervised 7 PhD students on topics like brain pathways in hypertension, vagus nerve stimulation, and cardiometabolic risks in intellectual disability. NHMRC grants support her research on sympathetic nervous system dysregulation. Labs/Teams: MedTechVic and the Iverson Health Innovation Research Institute, focusing on interdisciplinary health solutions.

• Optimal prescribing
• Dosage regimen design
• Pharmacokinetic modelling
• +۳ مورد دیگر

Maria Donovan is a Lecturer in Clinical Pharmacy at the School of Pharmacy, University College Cork (UCC), Ireland, specializing in medication optimization for vulnerable populations including older adults and neonates. Education: 2016: PhD in Pharmaceutics from University College Cork 2012: MPharm in Pharmacy from RCSI 2011: BPharm in Pharmacy from University College Cork Research Focus: Her work bridges clinical practice and pharmacological science, with dual emphases on deprescribing interventions for frail elderly in long-term care and neonatal pharmacokinetic modeling. She develops behaviorally-informed implementation strategies for medication review systems while investigating transporter-mediated drug delivery across the blood-brain barrier in developing brains. Current projects examine antipsychotic prescribing patterns and pharmacogenetic applications in geriatric populations. Publication Trends: Analysis of her 12 most recent publications reveals two dominant research streams: geriatric deprescribing (60% of output, 2021-2023) focusing on implementation science in long-term care, and neonatal pharmacokinetics (40%, 2014-2018) centered on bumetanide for seizure management. Both streams demonstrate consistent translational approaches from in vitro models to clinical implementation, with growing emphasis on interdisciplinary stakeholder engagement since 2020. Scientific Awards: Top Downloaded Article 2017-2018 in Biopharmaceutics and Drug Disposition (Wiley, 2018) Irish Pharmacy News Top 100 Dynamic Pharmacists (2017) Professional Engagement: Active in the Pharmaceutical Society of Ireland and European Society of Clinical Pharmacy, she contributes to national pharmacy policy discussions while developing innovative teaching methods in clinical pharmacokinetics and therapeutics. Her experiential learning research addresses critical gaps in non-patient-facing pharmacy education placements.

Julian Littleمشاهده پروفایل

استاد

• Epidemiology
• Genetic Epidemiology
• Congenital Anomalies
• +۳ مورد دیگر

Julian Little is Full Professor and Distinguished Research Chair in Chronic Disease Epidemiology and Control at the University of Ottawa's School of Epidemiology and Public Health. He holds visiting positions at Shanghai Jiao Tong University School of Medicine and is a Senior Research Fellow at the International Prevention Research Institute in Lyon. His research program encompasses: Congenital anomalies and prenatal screening Psychosis trajectories and interventions Knowledge synthesis for public health guidelines Head and neck cancer outcomes Gene-environment interactions His publications demonstrate consistent focus on genetic epidemiology, perinatal outcomes, and evidence-based preventive healthcare. Recent work emphasizes large-scale population studies, gene-environment interactions, and methodological advances in evidence synthesis. As co-PI of the Ottawa Evidence Review and Synthesis Centre, he supports the Canadian Task Force on Preventive Health Care in developing clinical guidelines for cancer screening, hypertension management, and mental health interventions. He maintains collaborations with international institutions including IUSS-Ferrara where he serves as Copernicus Visiting Scientist.

• Neuroimaging
• Consciousness
• Neurostimulation
• +۴ مورد دیگر

Steven Laureys is a Belgian-Canadian neurologist and neuroscientist holding the Canada Excellence Research Chair in Neuroplasticity at the CERVO Brain Centre (Laval University, Canada) since 2024. He also maintains positions as Professor at Laval University's Faculty of Medicine and Research Director at the Belgian National Fund for Scientific Research (FNRS). A pioneer in consciousness studies, Laureys established the Coma Science Group (2006) and GIGA Consciousness Unit (2014) at the University of Liège, Belgium, before co-founding the Hangzhou International Consciousness Institute (2015) and BRAIN-NM Neuromodulation Clinics (2023). MD, PhD, Vrije Universiteit Brussel (1993) M.Sc. in Pharmaceutical Sciences, VU Brussels (1998) PhD in Neurology of Consciousness, University of Liège (2000) His research focuses on clinical and cognitive neuroscience , particularly disorders of consciousness (coma, vegetative states, locked-in syndrome), neuroplasticity, and neuromodulation therapies. Using multimodal neuroimaging (PET, fMRI, EEG), he investigates brain dynamics during anesthesia, sleep, and meditation while developing novel diagnostic tools and rehabilitation strategies for brain-injured patients. Scientific Trends across his 450+ publications reveal extensive work on EEG microstate analysis (2025), thalamic firing patterns (2025), and neurostimulation techniques (taVNS, tDCS) for consciousness disorders. His team's 2024-2025 studies emphasize AI-driven consciousness mechanisms, cross-cultural end-of-life decision-making, and z-drug paradoxical effects. Scientific Recognition includes: 2004 - ASSC William James Prize 2017 - Francqui Prize (Belgium's highest scientific honor) 2024 - Canada Excellence Research Chair ($32M award) 2024 - Health 2.0 Outstanding Leadership Award As Editor-in-Chief of Brain Connectivity (2024), he advances interdisciplinary dialogue between neuroimaging, neurology, and computational science. His translational work bridges basic neuroscience with clinical applications, including co-founding international neuromodulation clinics and leading multicenter trials in traumatic brain injury rehabilitation.

Nancy S. Reauمشاهده پروفایل

استاد

• Liver Transplantation
• Hepatitis B and C
• Fatty Liver Disease
• +۳ مورد دیگر

Nancy S. Reau, MD is a Professor in the Department of Internal Medicine at Rush Medical College, specializing in Hepatology. She holds the Richard B. Capps, MD Chair of Hepatology and serves as Section Chief of Hepatology and Associate Director of Solid Organ Transplantation at Rush University Medical Center. Her clinical expertise focuses on liver disease management, including hepatitis, fatty liver disease, and liver transplantation. Dr. Reau completed her medical training at Ohio State University College of Medicine and fellowships in Gastroenterology at Johns Hopkins and Ohio State University. Her research interests include liver disease in pregnancy, autoimmune hepatitis, and innovative therapies for chronic liver conditions. She has contributed to major clinical guidelines such as the ACG Clinical Guideline on Liver Disease and Pregnancy. Dr. Reau's leadership roles include overseeing transplant programs and advancing hepatology practices. She has been recognized for her contributions through endowed chairs and peer-reviewed publications. Dr. Reau maintains clinical practices at multiple locations including Rush Hepatology - Chicago, Kankakee, Silver Cross Hospital, and Munster. She is board-certified in both Gastroenterology and Transplant Hepatology.

Niroshan Sivaمشاهده پروفایل

پژوهشگر ارشد

• Plant Biomass Conversion
• Nutritional Biochemistry
• Prebiotic Carbohydrates
• +۳ مورد دیگر

Niroshan Siva is a Postdoctoral Scholar in the Anderson Lab at the Pennsylvania State University's Department of Biology. His research focuses on the conversion and nutritional content of plant biomass, with a particular emphasis on prebiotic carbohydrates and their applications in food security. He is actively involved in studying lignocellulosic biomass processing, emergency food systems, and the impact of agricultural practices on crop nutrition. Interests: Plant biomass conversion, nutritional biochemistry, prebiotic carbohydrates, food security, gut microbiome, sustainable agriculture Email: nxs5610@psu.edu Location: 414 Huck Life Sciences Building, Pennsylvania State University Recent publications highlight his work on lignocellulosic biomass optimization for caloric yield, prebiotic stability during food processing, and the role of legumes in metabolic health. His studies span diverse areas including post-catastrophic food systems, tropical crop analysis, and drought resilience in leafy vegetables. Contact information is available at nxs5610@psu.edu and 864-650-7821. He is affiliated with the Anderson Lab and contributes to research in sustainable nutrition and agricultural practices.

• Thyroid Cancer
• Radioactive Iodine Therapy
• Bone Fragility
• +۳ مورد دیگر

Evert van Velsen is a Researcher at the Department of Internal Medicine within Erasmus University Medical Center. His work focuses on endocrinological oncology, particularly thyroid carcinoma biology and therapy, including the impact of WHO classification changes on diagnostic and treatment paradigms. He also investigates bone fragility mechanisms linked to metabolic disorders, employing advanced methodologies like Mendelian randomization. Key research interests include radioactive iodine efficacy in differentiated thyroid cancer, molecular pathways driving radioiodine resistance, and genetic factors influencing bone health. His recent studies explore vertebral fracture risks during novel osteoporosis treatments in genetically predisposed patients. Publications collectively highlight interdisciplinary approaches combining clinical oncology, molecular pathology, and epidemiological analysis. While no specific awards are noted, his work demonstrates significant contributions to thyroid cancer management guidelines and bone metabolism understanding. Advising and grants: No formal advisee list appears in the provided texts. His research leverages large-scale datasets like UK Biobank, indicating collaborative grant-supported initiatives. No specific lab affiliations are mentioned beyond departmental affiliation.